Skip to main content
Top
Published in: Pediatric Cardiology 7/2012

01-10-2012 | Images in Pediatric Cardiology

Pharmacologic Cardiac Resynchronization of a 1-Year-Old Boy With Severe Left Ventricular Dysfunction

Authors: Christian Paech, Patrick Flosdorff, Roman Antonin Gebauer

Published in: Pediatric Cardiology | Issue 7/2012

Login to get access

Abstract

Postero-septal accessory pathways (AP) are a rare cause of intraventricular dyssynchrony and severe LV dysfunction in children. Beside the common treatment with radiofrequency ablation of septal substrates we present the case of a successful pharmacologic resynchronization in a 13/12 years old male toddler with Wolff-Parkinson-White syndrome (WPW) and severe LV dysfunction (left ventricular biplane EF of 31 %) due to intraventricular dyssynchrony with septal to posterior wall motion delay (SPWMD) of 350 ms. Interventricular mechanical delay (IVMD) was 65 ms. Using propafenone, pharmacologic cardiac resynchronization could be achieved. Pharmacologic resynchronization should be considered as safe and effective alternative to catheter ablation in very young children.
Appendix
Available only for authorised users
Literature
1.
go back to reference Friedman RA, Walsh EP, Silka MJ, Calkins H, Stevenson WG, Rhodes LA, Deal BJ, Wolff GS, Demaso DR, Hanisch D, Van Hare GF (2002) NASPE Expert Consensus Conference: radiofrequency catheter ablation in children with and without congenital heart disease: report of the writing committee. North American Society of Pacing and Electrophysiology. Pacing Clin Electrophysiol 25:1000–1017PubMedCrossRef Friedman RA, Walsh EP, Silka MJ, Calkins H, Stevenson WG, Rhodes LA, Deal BJ, Wolff GS, Demaso DR, Hanisch D, Van Hare GF (2002) NASPE Expert Consensus Conference: radiofrequency catheter ablation in children with and without congenital heart disease: report of the writing committee. North American Society of Pacing and Electrophysiology. Pacing Clin Electrophysiol 25:1000–1017PubMedCrossRef
2.
go back to reference Janousek J, Paul T for the Working Group on Pediatric Arrhythmias and Electrophysiology of the Association of European Pediatric Cardiologists (1998) Safety of oral propafenone in the treatment of arrhythmias in infants and children (European Retrospective Multicenter Study). Am J Cardiol 81:1121–1124 Janousek J, Paul T for the Working Group on Pediatric Arrhythmias and Electrophysiology of the Association of European Pediatric Cardiologists (1998) Safety of oral propafenone in the treatment of arrhythmias in infants and children (European Retrospective Multicenter Study). Am J Cardiol 81:1121–1124
3.
go back to reference Paul T, Janousek J (1994) New antiarrhythmic drugs in pediatric use: propafenone. Pediatr Cardiol 15:190–197PubMedCrossRef Paul T, Janousek J (1994) New antiarrhythmic drugs in pediatric use: propafenone. Pediatr Cardiol 15:190–197PubMedCrossRef
4.
go back to reference Tomaske M, Janousek J, Razek V, Gebauer RA, Tomek V, Hindricks G, Knirsch W, Bauersfeld U (2008) Adverse effects of Wolff–Parkinson–White syndrome with right septal or posteroseptal accessory pathways on cardiac function. Europace 10:181–189PubMedCrossRef Tomaske M, Janousek J, Razek V, Gebauer RA, Tomek V, Hindricks G, Knirsch W, Bauersfeld U (2008) Adverse effects of Wolff–Parkinson–White syndrome with right septal or posteroseptal accessory pathways on cardiac function. Europace 10:181–189PubMedCrossRef
Metadata
Title
Pharmacologic Cardiac Resynchronization of a 1-Year-Old Boy With Severe Left Ventricular Dysfunction
Authors
Christian Paech
Patrick Flosdorff
Roman Antonin Gebauer
Publication date
01-10-2012
Publisher
Springer-Verlag
Published in
Pediatric Cardiology / Issue 7/2012
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-012-0310-z

Other articles of this Issue 7/2012

Pediatric Cardiology 7/2012 Go to the issue